Literature DB >> 2413166

Retrovirus-like particles in hepatocytes of patients with transfusion-acquired non-A, non-B hepatitis.

S Iwarson, Z Schaff, B Seto, G Norkrans, R J Gerety.   

Abstract

Retrovirus-like particles 60-85 nm in diameter were observed in the cytoplasm of hepatocytes in liver biopsies obtained during the acute and chronic phases of non-A, non-B hepatitis (NANBH) in three patients with transfusion-acquired disease. The particles appeared in dilated endoplasmic reticulum cisternae as well as in enlarged Golgi vesicles. No such particles were seen in hepatocytes in liver biopsies similarly obtained during the acute or chronic phases of NANBH from 11 additional patients with NANBH who did not acquire their disease following blood transfusion. Particle-associated reverse transcriptase activity (peak activity at a density of 1.14 gm/ml) was present in the sera of all three "particle-positive" patients and also in 42% of the "particle-negative" patients. The retrovirus-like particles described here were apparently unrelated to the previously described human T cell lymphocytotropic retroviruses (HTLV), since none of the 14 patients studied had antibodies in their serum directed against antigens of any of the three known HTLVs.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2413166     DOI: 10.1002/jmv.1890160106

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  3 in total

Review 1.  Non-A, non-B hepatitis: dead ends or new horizons?

Authors:  S A Iwarson
Journal:  Br Med J (Clin Res Ed)       Date:  1987-10-17

Review 2.  Viral hepatitis: new data on hepatitis C infection.

Authors:  Erzsébet Szabó; Gábor Lotz; Csilla Páska; András Kiss; Zsuzsa Schaff
Journal:  Pathol Oncol Res       Date:  2003-12-22       Impact factor: 3.201

3.  A glycoprotein associated with the non-A, non-B hepatitis agent(s): isolation and immunoreactivity.

Authors:  B Seto; R J Gerety
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.